Who is sponsoring NCT03804619?

NCT03804619 is sponsored by Stanford University.

What condition does NCT03804619 study?

NCT03804619 studies Opiate Dependence, Suicidal Ideation, Depression, Opioid Use, Opioid-Related Disorders, Opioid-use Disorder, Major Depressive Disorder.

Is NCT03804619 still recruiting?

NCT03804619 is currently withdrawn. Last updated 16 July 2024.

Last reviewed 2024-07-16 · How we verify

NCT03804619

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Accelerated Intermittent Theta-Burst Stimulation for Opiate Use Disorder

Withdrawn NA Last updated 16 July 2024

What this trial tests

NA trial testing Accelerated intermittent theta-burst stimulation (aiTBS) in Opiate Dependence. Withdrawn.

Timeline

1 January 2024

Primary endpoint
11 July 2024

11 July 2024

Quick facts

Lead sponsor	Stanford University
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Start date	1 January 2024
Primary completion	11 July 2024
Estimated completion	11 July 2024
Sites	1 location across United States

Drugs / interventions tested

Accelerated intermittent theta-burst stimulation (aiTBS)

Conditions studied

Opiate Dependence — all drugs for Opiate Dependence →
Suicidal Ideation — all drugs for Suicidal Ideation →
Depression — all drugs for Depression →
Opioid Use — all drugs for Opioid Use →

Sponsor

Stanford University

Who can join

18 and older, any sex, with Opiate Dependence or Suicidal Ideation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to examine whether multiple spaced sessions of intermittent theta-burst transcranial magnetic stimulation (iTBS) induce anti-depressant responses and reduce opiate cravings in adults with opiate use disorder (OUD). Additionally, we hope to identify whether the effectiveness of iTBS is related to changes in functional connectivity between particular brain areas.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A Systematic Review of Noninvasive Brain Stimulation for Opioid Use Disorder.
Ward HB, Mosquera MJ, Suzuki J, Mariano TY. · · 2020 · cited 13× · PMID 32059080 · DOI 10.1111/ner.13108

Verify or expand the search:

Other Stanford University trials

Trials by the same sponsor.

NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
NCT04225949 — Patients Understanding of PROM Graphs · NA · withdrawn
NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03804619 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Stanford University
Last refreshed: 16 July 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03804619.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing